The Autoimmune Interstitial Lung Disease (ILD) Panel is a specialized blood test designed to detect antibodies associated with autoimmune conditions that can affect the lungs. Interstitial lung diseases often result from immune system dysfunction, leading to inflammation and scarring of lung tissue. This panel helps identify underlying autoimmune causes, guiding accurate diagnosis and treatment. It is particularly useful for patients with unexplained respiratory symptoms, suspected connective tissue disorders, or progressive lung disease.
It helps diagnose autoimmune-related lung disease early, guiding treatment decisions and preventing progression of lung scarring, which can severely affect breathing and quality of life.
Patients with unexplained respiratory symptoms, suspected connective tissue disorders, or progressive lung disease are usually recommended for this test to identify autoimmune involvement.
It does not confirm ILD alone but helps identify autoimmune causes. Diagnosis usually involves combining test results with imaging and clinical evaluation.
A positive result indicates autoimmune antibodies are present, suggesting immune-related lung disease. Health care professional may recommend immunosuppressive therapy or further evaluation.
A negative result means no autoimmune antibodies were detected, but other causes of interstitial lung disease may still need investigation.
Without testing, autoimmune-related lung disease may remain undiagnosed, leading to progressive scarring, breathing difficulties, and reduced treatment options.
While autoimmune conditions cannot always be prevented, early detection through this test allows timely treatment to slow disease progression.
...
Didn't recieved OTP Yet? Resend OTP